As filed with the United States Securities and Exchange Commission on December 15, 2023
Registration No. 333-252514
Registration No. 333-257893
Registration No. 333-263946
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549
Post-Effective Amendment No. 1 (333-252514)
Post-Effective Amendment No. 1 (333-257893)
Post-Effective Amendment No. 1 (333-263946)
to
FORM S-8
REGISTRATION STATEMENT
UNDER
THE SECURITIES ACT OF 1933
Abcam Limited
(Exact name of registrant as specified in its charter)
| | |
United Kingdom | | Not Applicable |
(State or other jurisdiction of incorporation or organization) | | (I.R.S. Employer Identification Number) |
| |
Discovery Drive Cambridge Biomedical Campus Cambridge, CB2 0AX United Kingdom | | Not Applicable |
(Address of Principal Executive Offices) | | (Zip Code) |
ABCAM PLC LONG-TERM INCENTIVE PLAN
ABSHARE
THE ABCAM PLC ANNUAL BONUS PLAN
ABCAM 2005 SHARE OPTION SCHEME
THE ABCAM 2015 SHARE OPTION PLAN
ABCAM PLC PROFITABLE GROWTH INCENTIVE PLAN
ABCAM PLC GROWTH PLAN
(Full title of the plan)
Abcam Inc.
152 Grove Street
Suite 1100
Waltham, Massachusetts
02453
(Name and address of agent for service)
(888) 772-2226
(Telephone number, including area code, of agent for service)
Copies to:
Lorenzo Corte, Esq.
Skadden, Arps, Slate, Meagher & Flom (UK) LLP
22 Bishopsgate
London EC2M 4BQ
United Kingdom
+44 20 7519 7000
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. See the definitions of “large accelerated filer”, “accelerated filer,” “smaller reporting company” and “emerging growth company” in Rule 12b-2 of the Exchange Act.
| | | | | | |
Large Accelerated Filer | | ☒ | | Accelerated Filer | | ☐ |
| | | |
Non-Accelerated Filer | | ☐ | | Smaller reporting company | | ☐ |
| | | |
| | | | Emerging growth company | | ☐ |
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 7(a)(2)(B) of the Securities Act. ☐